Evidence map›Paper›PMID 32111794›Full record

ArticleIn vivo (Athens, Greece)

Distribution of Regulatory T-Cells and Other Phenotypes of T-Cells in Tumors and Regional Lymph Nodes of Colorectal Cancer Patients.

Keisuke Kazama, Junya Otake, Tetsuta Satoyoshi, Manabu Shiozawa, Nobuhiro Sugano, Sumito Sato, Yosuke Atsumi, Kazuki Kano, Masaaki Murakawa, Yukio Maezawa and 7 more

Open access · diamondAbstract read
In one paragraph

Article in In vivo (Athens, Greece). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 1 country.

Keisuke Kazama *Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Japan c_falcon_kk@yahoo.co.jp.
Junya OtakeCancer Vaccine Center, Kanagawa Cancer Center, Yokohama, Japan.
Tetsuta SatoyoshiDepartment of Surgery, Yokohama City University, Yokohama, Japan.
Manabu ShiozawaDepartment of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Japan.
Nobuhiro SuganoDepartment of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Japan.
Sumito SatoDepartment of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Japan.
Yosuke AtsumiDepartment of Surgery, Yokohama City University, Yokohama, Japan.
Kazuki KanoDepartment of Surgery, Yokohama City University, Yokohama, Japan.
Masaaki MurakawaDepartment of Surgery, Yokohama City University, Yokohama, Japan.
Yukio MaezawaDepartment of Surgery, Yokohama City University, Yokohama, Japan.
Itaru HashimotoDepartment of Surgery, Yokohama City University, Yokohama, Japan.
Masakatsu NumataDepartment of Surgery, Yokohama City University, Yokohama, Japan.
Takashi OshimaDepartment of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Japan.
Norio YukawaDepartment of Surgery, Yokohama City University, Yokohama, Japan.
Yasushi RinoDepartment of Surgery, Yokohama City University, Yokohama, Japan.
Tetsuro SasadaCancer Vaccine Center, Kanagawa Cancer Center, Yokohama, Japan.
Munetaka MasudaDepartment of Surgery, Yokohama City University, Yokohama, Japan.
Yokohama City University · JPKanagawa Prefectural Hospital Organization · JPKanagawa Cancer Center

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

aimTumor microenvironments consist of many types of immune cells, in which regulatory T-cells (Tregs) are supposed to play important roles to suppress anti-tumor immunity. Regional lymph nodes are essential for antitumor immunity in colorectal cancer (CRC). In this study, we compared the diversity of phenotypes of T-cells in normal tissue and regional lymph nodes in order to determine the immunosuppressive mechanism of lymph node metastasis of CRC. PATIENTS AND

methodsFifty patients were enrolled in this study, and paired samples (tumor tissue, normal tissue, and three regional lymph node samples and as well as non-regional lymph node samples) were obtained from each patient. In each paired-sample set, the proportions of different immune cell types and T-cells expressing immune checkpoint molecules were compared using flow cytometry.

resultsHigher proportions of Tregs [7.58% (4.94%-13.87%) vs. 1.79% (0.03%-5.36%), p<0.001] and lower proportions of INFγ-producing CD4-positive T (iCD4+) cells [21.49% (12.08%-27.35%) vs. 26.55% (15.65%-37.63%), p<0.001] were observed in tumor tissue than in normal mucosa. Parts of regional lymph nodes nearest the tumor had a greater proportion of Tregs [5.86% (4.18%-7.69%)] and lower proportions of iCD4+ [5.94% (3.51%-9.04%)] and INFγ-producing CD8-positive T (iCD8+) cells [21.93% (14.92%-35.90%)] than distant parts of regional lymph nodes and non-regional lymph nodes. Both immune-suppressing molecules (CTLA-4 and PD-1) and immune-promoting molecules (OX-40 and ICOS) tended to be highly expressed in tumor tissue and local lymph nodes.

conclusionIn patients with CRC, regional lymph nodes, especially the parts nearest the tumor, had a higher proportion of Tregs and other suppressive immunophenotypes of T-cells than those located more distantly.

Indexed as

BiomarkersColorectal NeoplasmsFemaleFlow CytometryHumansImmunophenotypingLymphatic MetastasisLymph NodesLymphocyte CountLymphocytes, Tumor-InfiltratingMaleNeoplasm StagingPhenotypeT-Lymphocytes, RegulatoryT-Lymphocyte SubsetsTumor MicroenvironmentBiomarkerscolorectal cancerimmune check pointlymph nodeRegulatory T-cells

Identifiers

PMID32111794
PMCPMC7157850
OpenAlexW3007206695

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.